Exelon Panel To Debate Parkinson’s-Related Dementia As Distinct Condition
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis’ sNDA for the Alzheimer’s therapy is the first application for a Parkinson’s-related dementia indication.